Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Eton Pharmaceuticals (ETON) Non-Current Debt: 2024-2025

  • Eton Pharmaceuticals' Non-Current Debt was N/A to $27.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $27.6 million, marking a year-over-year change of. This contributed to the annual value of $29.8 million for FY2024, which is N/A change from last year.
  • As of Q3 2025, Eton Pharmaceuticals' Non-Current Debt stood at $27.6 million, which was up 0.66% from $27.4 million recorded in Q2 2025.
  • Over the past 5 years, Eton Pharmaceuticals' Non-Current Debt peaked at $29.8 million during Q4 2024, and registered a low of $27.4 million during Q2 2025.
  • For the 2-year period, Eton Pharmaceuticals' Non-Current Debt averaged around $28.3 million, with its median value being $27.6 million (2025).